Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)
Clinical trial NCT06060665 · COMPLETED
Trial details
- NCT number
- NCT06060665
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-05
- Primary completion
- 2026-05-06
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.